Lupin appoints Brian Savage as President and Chief Legal Officer
Savage will lead Lupin’s global Legal, Compliance and Intellectual Property Management Group functions and will be based in New…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin receives tentative approval from US FDA for novel Apixaban Oral Suspension
Global pharma major, Lupin announced that it has received tentative approval from the United States Food and Drug Administration…
Lupin receives US FDA approval for Modafinil Tablets, USP
Global pharma major Lupin announced that it has received approval from the United States Food and Drug Administration (US FDA) for…
Lupin gets US FDA nod for sodium zirconium cyclosilicate
The drug is bioequivalent to AstraZeneca’s Lokelma and indicated for hyperkalaemia in adults
Lupin announces US FDA approval and launch of Sugammadex injection
Global pharma major Lupin announced that following approval from the United States Food and Drug Administration (US FDA) for its…
Lupin spins out two oncology programs to Kaveri Therapeutics to advance its oncology strategy
Global pharma major Lupin, announced the strategic spin-out of two oncology programs – LNP7457 (PRMT5) and LNP8701 (SOS1), …
Lupin gets tentative nod from US FDA for Enzalutamide tablets
The tentative approval covers the 40 mg, 80 mg, 120 mg, and 160 mg strengths
Lupin collaborates with ERN for Luforbec pMDI launch in Spain
Global pharma major Lupin announced its strategic collaboration with LABORATORIOS ERN S.A. (ERN), a well‑established Spanish…
Lupin, Natco receive US FDA approval for Eribulin Mesylate Injection
ANDA approval covers Eribulin Mesylate Injection, the bioequivalent of Halaven Injection, for metastatic breast cancer and…
Lupin receives US FDA approval for generic colonoscopy preparation tablets
Approval grants Lupin 180-day generic drug exclusivity for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets in…